Affinity Technologies, Inc. ( ($BIAF) ) has issued an update. On October 16, 2025, bioAffinity Technologies, Inc. announced it received a ...
A new multi-site study, published in JAMA, and co-led by researchers at the UNC Lineberger Comprehensive Cancer Center and ...
Among patients in a lung cancer screening registry, cancer survivors had similar outcomes as those with no prior cancer — but their rate of lung cancer detection was numerically higher. Cancer ...
Southern Illinois Healthcare (SIH) has introduced a groundbreaking advancement in lung care for the region. SIH Memorial ...
An alliance of scientists at the Broad Institute and Bayer Pharmaceuticals have developed a drug candidate, sevabertinib, ...
The National Institutes of Health has awarded nearly a half-million dollars to two University of Dayton researchers exploring strategies for the detection and potential treatment of non-small cell ...
Please provide your email address to receive an email when new articles are posted on . Guidelines for the management of early-stage non-small cell lung cancer were last published in 2013. The new ...
The Avantect Multi-Cancer Detection Test is a simple blood test designed to screen for several types of cancer simultaneously in asymptomatic, generally healthy persons. It targets some of the ...
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today released ...
SAN ANTONIO — October is Breast Cancer Awareness Month. The disease is the second leading cause of cancer death in women. Breast cancer rates have dropped by close to 50% since the 1980s. A lot of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback